These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 39042569)

  • 1. Death Risk Response of High-Altitude Resident Populations to COVID-19 Vaccine: A Retrospective Cohort Study.
    Vásquez-Velásquez C; Fano-Sizgorich D; Gonzales GF
    High Alt Med Biol; 2024 Jul; ():. PubMed ID: 39042569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality Attributed to COVID-19 in High-Altitude Populations.
    Woolcott OO; Bergman RN
    High Alt Med Biol; 2020 Dec; 21(4):409-416. PubMed ID: 32815745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living at High Altitude and COVID-19 Mortality in Peru.
    Nicolaou L; Steinberg A; Carrillo-Larco RM; Hartinger S; Lescano AG; Checkley W
    High Alt Med Biol; 2022 Jun; 23(2):146-158. PubMed ID: 35483043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Excess Mortality Data at Different Altitudes During the COVID-19 Outbreak in Ecuador.
    Ortiz-Prado E; Fernandez Naranjo RP; Vasconez E; Simbaña-Rivera K; Correa-Sancho T; Lister A; Calvopiña M; Viscor G
    High Alt Med Biol; 2021 Dec; 22(4):406-416. PubMed ID: 34905395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Protective Effect from COVID-19 Conferred by Altitude: A Longitudinal Analysis in Peru During Full Lockdown.
    Thomson TM; Casas F; Guerrero HA; Figueroa-Mujíca R; Villafuerte FC; Machicado C
    High Alt Med Biol; 2021 Jun; 22(2):209-224. PubMed ID: 33780636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study.
    Xu S; Hong V; Sy LS; Bruxvoort KJ; Lewin B; Han B; Holmquist KJ; Qian L
    JMIR Public Health Surveill; 2023 Oct; 9():e46318. PubMed ID: 37792452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A U-shaped protection of altitude against mortality and infection of COVID-19 in Peru: an ecological study.
    Baquerizo-Sedano L; Goni L; Sayón-Orea C; González-Muniesa P
    BMC Public Health; 2023 Jun; 23(1):1054. PubMed ID: 37264338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study.
    Piernas C; Patone M; Astbury NM; Gao M; Sheikh A; Khunti K; Shankar-Hari M; Dixon S; Coupland C; Aveyard P; Hippisley-Cox J; Jebb SA
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):571-580. PubMed ID: 35780805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13 062 positive pregnancies including 176 maternal deaths in Mexico.
    Torres-Torres J; Martinez-Portilla RJ; Espino-Y-Sosa S; Estrada-Gutierrez G; Solis-Paredes JM; Villafan-Bernal JR; Medina-Jimenez V; Rodriguez-Morales AJ; Rojas-Zepeda L; Poon LC
    Ultrasound Obstet Gynecol; 2022 Jan; 59(1):76-82. PubMed ID: 34672382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Nyberg T; Ferguson NM; Nash SG; Webster HH; Flaxman S; Andrews N; Hinsley W; Bernal JL; Kall M; Bhatt S; Blomquist P; Zaidi A; Volz E; Aziz NA; Harman K; Funk S; Abbott S; ; Hope R; Charlett A; Chand M; Ghani AC; Seaman SR; Dabrera G; De Angelis D; Presanis AM; Thelwall S
    Lancet; 2022 Apr; 399(10332):1303-1312. PubMed ID: 35305296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Vaccination on COVID-19 Severity and Outcome: A Comparative Study in a Tertiary Care Hospital.
    Yadav YR; Maheshwari S; Garg A; Ram A; Singh S; Mangal S; Maheshwari K; Notani V; Sharma S; Bansal V
    J Assoc Physicians India; 2023 Dec; 71(12):14-16. PubMed ID: 38736048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn and Early Infant Outcomes Following Maternal COVID-19 Vaccination During Pregnancy.
    Jorgensen SCJ; Drover SSM; Fell DB; Austin PC; D'Souza R; Guttmann A; Buchan SA; Wilson SE; Nasreen S; Schwartz KL; Tadrous M; Wilson K; Kwong JC
    JAMA Pediatr; 2023 Dec; 177(12):1314-1323. PubMed ID: 37870875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 in City Council Civil Servants, 1 March 2020-31 January 2023: Risk of Infection, Reinfection, Vaccine Effectiveness and the Impact of Heterologous Triple Vaccination.
    Cegolon L; Larese Filon F
    Vaccines (Basel); 2024 Feb; 12(3):. PubMed ID: 38543888
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    Gram MA; Nielsen J; Schelde AB; Nielsen KF; Moustsen-Helms IR; Sørensen AKB; Valentiner-Branth P; Emborg HD
    PLoS Med; 2021 Dec; 18(12):e1003874. PubMed ID: 34919548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.
    Chemaitelly H; Ayoub HH; AlMukdad S; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
    Lancet Microbe; 2022 Dec; 3(12):e944-e955. PubMed ID: 36375482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of death, hospitalization and intensive care unit admission by SARS-CoV-2 variants in Peru: a retrospective study.
    Fano-Sizgorich D; Vásquez-Velásquez C; Orellana LR; Ponce-Torres C; Gamboa-Serpa H; Alvarez-Huambachano K; Gonzales GF
    Int J Infect Dis; 2023 Feb; 127():144-149. PubMed ID: 36563957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
    Hippisley-Cox J; Coupland CA; Mehta N; Keogh RH; Diaz-Ordaz K; Khunti K; Lyons RA; Kee F; Sheikh A; Rahman S; Valabhji J; Harrison EM; Sellen P; Haq N; Semple MG; Johnson PWM; Hayward A; Nguyen-Van-Tam JS
    BMJ; 2021 Sep; 374():n2244. PubMed ID: 34535466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and factors associated with food insecurity in eight high-altitude cities in Peru during the second wave of the COVID-19 pandemic: a retrospective, cross-sectional study.
    Zila-Velasque JP; Grados-Espinoza P; Quispe-Chura K; Valdiviezo-Morales CG; Diaz-Vélez C; Valladares-Garrido MJ
    BMC Public Health; 2022 Oct; 22(1):1962. PubMed ID: 36284287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.